Valuation: Gulf Pharmaceutical Industries

Capitalization 1.36B 371M 316M 293M 275M 512M 33.99B 543M 3.35B 1.33B 16.06B 1.39B 58.76B P/E ratio 2025 *
-
P/E ratio 2026 * 13.1x
Enterprise value 1.42B 387M 329M 306M 286M 533M 35.41B 566M 3.49B 1.38B 16.73B 1.45B 61.21B EV / Sales 2025 *
1.04x
EV / Sales 2026 * 0.93x
Free-Float
30.76%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.85%
1 week+1.71%
Current month+1.71%
1 month-3.25%
3 months-4.80%
6 months-15.60%
Current year+1.71%
More quotes
1 week 1.16
Extreme 1.16
1.26
1 month 1.09
Extreme 1.09
1.26
Current year 1.14
Extreme 1.14
1.26
1 year 1.04
Extreme 1.04
1.63
3 years 0.7
Extreme 0.701
1.78
5 years 0.7
Extreme 0.701
2.32
10 years 0.7
Extreme 0.701
4.51
More quotes
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer - -
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member - 01/01/2017
Director/Board Member - 01/01/2019
Chairman - 01/01/2005
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.85%+1.71%-21.19%+8.18% 371M
-1.09%-1.88%-11.67%-33.81% 65.59B
+1.59%+3.16%+15.53%-7.93% 8.62B
-0.59%-0.74%+28.96%+38.53% 8.38B
+1.93%-2.84%+6.80%+62.06% 6.21B
+1.95%-3.14%-19.01%+106.07% 5.34B
+1.70%+1.99%+177.65%+36.90% 4.19B
-2.23%-4.89%-16.82%-22.35% 2.88B
-5.27%+1.99%+56.43%+43.35% 2.77B
-0.85%-2.31%+28.64%+21.81% 2.82B
Average -0.20%-0.93%+24.53%+25.28% 10.72B
Weighted average by Cap. -0.53%-0.59%+4.45%-6.87%
See all sector performances

Financials

2025 *2026 *
Net sales 1.36B 371M 316M 293M 275M 512M 33.99B 543M 3.35B 1.33B 16.05B 1.39B 58.75B 1.43B 390M 332M 309M 289M 539M 35.76B 571M 3.52B 1.4B 16.89B 1.46B 61.81B
Net income 206M 56.08M 47.73M 44.33M 41.56M 77.39M 5.14B 82.06M 506M 201M 2.43B 210M 8.88B 102M 27.77M 23.63M 21.95M 20.58M 38.32M 2.54B 40.63M 251M 99.31M 1.2B 104M 4.4B
Net Debt 56.8M 15.46M 13.16M 12.22M 11.46M 21.34M 1.42B 22.63M 140M 55.3M 669M 57.99M 2.45B -25.7M -7M -5.95M -5.53M -5.19M -9.66M -641M -10.24M -63.14M -25.02M -303M -26.24M -1.11B
More financial data * Estimated data
Logo Gulf Pharmaceutical Industries
Gulf Pharmaceutical Industries PSC (Julphar) is a United Arab Emirates-based public shareholding company engaged in manufacturing and selling of medicines, drugs and other types of pharmaceutical and medical compounds, in addition to cosmetic compounds. The Company maintains a range of product portfolio, which target major therapeutic segments, including endocrinology, anti-infective, cardiovascular and gastroenterology, over-the-counter, nephrology, dermatology, respiratory, metabolic and burn and wound management. The Company operates through a network of more than 10 manufacturing plants, and a logistics network. The Company has approximately 800 products in various dosage forms, and more in the pipeline. The Company’s subsidiaries include Mena Cool FZE, which is engaged in the transportation, and Julphar Pharmaceuticals PLC, which is engaged in Manufacturing of medicines, wrapping and packing materials.
Employees
2,400
More about the company
Date Price Change Volume
23/01/26 1.200 AED +1.69% 1,701,057
22/01/26 1.180 AED +0.85% 8,458,804
21/01/26 1.170 AED -1.68% 2,796,908
20/01/26 1.190 AED -0.83% 1,845,362
19/01/26 1.200 AED +2.56% 5,334,201

Delayed Quote Abu Dhabi Securities Exchange, January 23, 2026 at 12:29 pm

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.180AED
Average target price
1.720AED
Spread / Average Target
+45.76%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. JULPHAR Stock